Sponsor:
Alnylam Pharmaceuticals
Code:
NCT05040373
Conditions
Hereditary Transthyretin-mediated (hATTR) Amyloidosis
Polyneuropathy
Eligibility Criteria
Sex: Female
Age: 0 - 70+
Healthy Volunteers: Not accepted
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations